Medicated chewing gums have a wide range of applications in health care, including drug delivery and neutraceuticals. These gums are used for the prevention and treatment of motion sickness and dental caries and smoking for cessation. The popularity of chewing gums as drug delivery systems is increasing due to their advantages such as non-invasiveness, easy administration, and faster metabolism through the liver or gut wall. Moreover, the trend of using biodegradable chewing gums is increasing due to a ban on synthetic polymer-based chewing gums in Singapore and other parts of the world.

Factors driving the growth of the global medicated chewing gums market are large population base addicted to smoking and increase in awareness about dental hygiene and bad breath. Additionally, an increase in demand for medicated chewing gums in neutraceuticals and drug delivery are anticipated to fuel the market during the forecast period. Furthermore, a large number of variants of nicotine gum manufactured by market players, including various flavors such as mint and fruits, is expected to fuel the medicated chewing gums market. Moreover, an increase in the use of chewing gums as drug delivery systems for the prevention and treatment of nausea and motion sickness is expected to offer growth opportunities to the medicated chewing gums market.

Request Brochure of Medicated Chewing Gums Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59766

The global medicated chewing gums market can be segmented based on product, application, and region. In terms of product, the medicated chewing gums market can be divided into pellets, hollow balls, liquid-filled gum, others. The pellets segment is projected to account for a major market share during the forecast period due to an increase in the availability of medicated chewing gums in the pellet form.  Based on application, the global medicated chewing gums market can be classified into smoking cessation, dental hygiene, motion sickness, dental caries, and others. The smoking cessation segment is anticipated to be driven by a rise in addiction to smoking and increase in awareness about smoking cessation methods among men and women.

In terms of region, the global medicated chewing gums market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The medicated chewing gums market in North America is anticipated to exhibit significant growth due to factors such as increase in the number of adults addicted to smoking and significant demand for dental hygiene products such as chewing gums and mouth washes. The medicated chewing gums market in Europe is projected to expand at a rapid pace during the forecast period, due to a significant presence of market players manufacturing nicotine-based medicated chewing gums and expansion of the neutraceutical industry in countries such as Germany, France, and the U.K..

The medicated chewing gums market in Asia Pacific is expected to be driven by a rise in the number of consumers using medicated chewing gum and active pharmaceutical ingredient (API) manufacturers and increasing importance of dental healthcare due to a rise in the prevalence of dental caries. Furthermore, a rise in the number of government initiatives for smoking cessation is anticipated to fuel the market in emerging economies such as China and India. In India, research and innovation is one of the key factors responsible for the growth of health care technologies. For instance, the School of Pharmaceutical and Sciences, Rajiv Gandhi Proudyog Vishwavidyala (RGPV), developed a biodegradable medical chewing gum for travelers with motion sickness. Furthermore, outsourcing of manufacturing processes by Enorama Pharma to Aizant, a contract manufacturing organization (CRO) company in India, is expected to offer growth opportunities to the medicated chewing gums market in India.

Key players operating in the global Medicated Chewing Gums market are Fertin Pharma, Skyepharma Production SAS, Alkalon A/S, GlaxoSmithKline, ENORAMA PHARMA AB, Mastix LLC, Omega Pharma Ltd, a subsidiary of Perrigo Company Plc., Agro Gums, Perfetti Van Melle, and WM. Wrigley Jr. Company.

Pre Book Medicated Chewing Gums Market Report –

https://www.transparencymarketresearch.com/checkout.php?rep_id=59766&ltype=S

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Tags: